Comparison of Photorefractive Keratectomy (PRK) and Sub-Bowman's Keratomileusis (SBK)

Sponsor
University of Utah (Other)
Overall Status
Completed
CT.gov ID
NCT00714922
Collaborator
(none)
60
1
2
35
1.7

Study Details

Study Description

Brief Summary

The objective of the study is to compare clinical outcomes from PRK and SBK using FDA-approved laser technology in the same patient

Condition or Disease Intervention/Treatment Phase
  • Procedure: PRK
  • Procedure: SBK
N/A

Detailed Description

Patients undergoing bilateral laser refractive surgery on the same day will be randomly assigned to have one eye treated with PRK and the fellow eye treated with SBK.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison of Photorefractive Keratectomy (PRK) and Sub-Bowman's Keratomileusis (SBK): Assessment of Visual Function and Patient Satisfaction
Study Start Date :
Oct 1, 2007
Actual Primary Completion Date :
Sep 1, 2010
Actual Study Completion Date :
Sep 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: 1

PRK

Procedure: PRK
Laser refractive surgery

Active Comparator: 2

SBK

Procedure: SBK
Laser refractive surgery

Outcome Measures

Primary Outcome Measures

  1. Visual acuity [6 months]

Secondary Outcome Measures

  1. Manifest refraction [6 months]

  2. Wavefront aberration value [6 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients deemed to be suitable candidates for bilateral LASIK surgery
Exclusion Criteria:
  • Patients who desire monovision correction rather than bilateral distance correction

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Utah, John Moran Eye Center Salt Lake City Utah United States 84106

Sponsors and Collaborators

  • University of Utah

Investigators

  • Principal Investigator: Majid Moshirfar, MD, University of Utah

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00714922
Other Study ID Numbers:
  • 25516
First Posted:
Jul 14, 2008
Last Update Posted:
Sep 16, 2010
Last Verified:
Sep 1, 2010
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 16, 2010